MMP1 Antibody
Description
Introduction
The MMP1 Antibody is a specific immunoglobulin designed to detect and analyze matrix metalloproteinase-1 (MMP-1), an enzyme critical for extracellular matrix (ECM) remodeling. Its applications span cancer research, cardiovascular diseases, and autoimmune disorders, with studies highlighting its role as a prognostic biomarker .
MMP1 Antibody Overview
-
Target: MMP-1, a 54 kDa zinc-dependent endopeptidase that cleaves collagen types I, II, and III .
-
Applications:
Research Findings
-
Cancer Prognosis:
-
Cardiovascular Diseases:
-
Neurological Disorders:
Clinical Implications
Product Specs
Target Background
KEGG: sce:YLL061W
STRING: 4932.YLL061W
Customer Reviews
Applications : WB
Sample type: Human HaCaT human keratinocytes
Review: Expression level of MMP-1 was analyzed by western blot analysis. Actin was used as a loading control. * p < 0.05 compared with untreated cells.
Q&A
What is MMP-1 and what is its biological significance?
MMP-1, also known as interstitial or fibroblast collagenase, is a 469 amino acid zinc-dependent endopeptidase in its pro-peptide form. It primarily degrades collagens I, II, and III, which are main components of the interstitial stroma . Beyond matrix degradation, MMP-1 plays crucial roles in cell proliferation, migration, differentiation, and apoptosis . Like most MMPs, it's synthesized as an inactive zymogen requiring cleavage of a propeptide region for activation .
MMP-1 is significantly upregulated in various cancers, where it indicates invasive disease and poor prognosis . It's overexpressed in invasive melanoma, colorectal, and esophageal cancers . Additionally, MMP-1 is implicated in inflammatory conditions like arthritis, atherosclerotic lesion formation, and repair processes following myocardial infarction . The ability to accurately detect and quantify MMP-1 is therefore essential for understanding numerous physiological and pathological processes.
What types of MMP-1 antibodies are available for research?
Several types of MMP-1 antibodies are available for research applications, each with specific characteristics:
| Antibody Type | Clone Examples | Target Specificity | Recommended Applications |
|---|---|---|---|
| Monoclonal | 36665 (MAB901) | Human MMP-1 | WB, IHC |
| Monoclonal | 3B6 | Human MMP-1 | WB, IHC |
| Form-specific | MAB3223 | Active MMP-1 only | WB |
| Polyclonal | AF901 | Human MMP-1 | Various applications |
Monoclonal antibodies like clone 36665 recognize specific epitopes within the MMP-1 protein, with the antibody recognizing amino acids Phe20-Asn469 of human MMP-1 . Some antibodies can differentiate between the pro-form (approximately 54 kDa) and active form (approximately 42-45 kDa) of MMP-1, which is crucial for studying MMP-1 activation in different physiological and pathological contexts .
What is the difference between antibodies targeting pro-MMP-1 versus active MMP-1?
Understanding the distinction between pro-MMP-1 and active MMP-1 antibodies is crucial for experimental design:
| Characteristic | Pro-MMP-1 Antibodies | Active MMP-1 Antibodies |
|---|---|---|
| Target | Full-length protein with propeptide | Cleaved, enzymatically active form |
| Molecular Weight | ~54 kDa | ~42-45 kDa |
| Example | MAB901 | MAB3223 |
| Typical Applications | Measuring total MMP-1 expression | Assessing MMP-1 activation |
| Complementary Assays | RT-PCR, total protein quantification | Zymography, activity assays |
Some antibodies like MAB901 may detect both forms, while others like MAB3223 are specifically designed to detect only the active form . When studying MMP-1 activation mechanisms, it's advisable to use both types of antibodies in parallel or complement protein detection with functional activity assays like casein zymography .
What are the optimal conditions for using MMP-1 antibodies in Western blotting?
Based on published protocols, the following conditions are recommended for optimal Western blot detection of MMP-1:
| Parameter | Recommended Condition |
|---|---|
| Membrane | PVDF |
| Conditions | Reducing |
| Buffer System | Immunoblot Buffer Group 1 |
| Primary Antibody | 2 μg/mL (typical concentration) |
| Secondary Antibody | HRP-conjugated Anti-Mouse IgG |
| Expected Band Size | ~54 kDa (pro-form), ~42-45 kDa (active form) |
| Loading Control | GAPDH or β-actin |
| Sample Preparation | Cell lysate or concentrated culture media |
Western blot analysis from multiple studies shows that MMP-1 typically appears as a specific band at approximately 54 kDa under reducing conditions when using antibodies like MAB901 . The specificity can be confirmed using MMP-1 knockout cell lines as negative controls, as demonstrated with PC-3 prostate cancer parental and MMP-1 knockout cell lines .
How should samples be prepared for MMP-1 detection in immunohistochemistry?
For successful immunohistochemical detection of MMP-1, follow these methodological guidelines:
| Step | Recommendation |
|---|---|
| Tissue Preparation | Immersion-fixed, paraffin-embedded sections |
| Antibody Concentration | 25 μg/mL (typical for MAB901) |
| Incubation | Overnight at 4°C |
| Detection System | Anti-Mouse HRP-AEC or HRP-DAB Cell & Tissue Staining Kit |
| Counterstain | Hematoxylin |
| Controls | Omit primary antibody as negative control |
| Validated Tissues | Ovarian cancer tissue shows positive staining |
Immunohistochemical analysis has successfully detected MMP-1 in human ovarian cancer tissue using the protocols described above . The staining pattern shows specific localization of MMP-1, which can be compared across different tissue samples or experimental conditions to assess relative expression levels and tissue distribution .
What controls should be included when using MMP-1 antibodies?
Rigorous experimental design requires appropriate controls:
| Control Type | Example | Purpose |
|---|---|---|
| Positive Control | PC-3 prostate cancer cells | Confirm antibody functionality |
| Negative Control (Genetic) | MMP-1 knockout PC-3 cell line | Verify antibody specificity |
| Technical Negative Control | Omit primary antibody | Check for non-specific secondary binding |
| Loading Control (WB) | GAPDH or β-actin | Normalize protein loading |
| mRNA Correlation | RT-PCR analysis of MMP-1 expression | Confirm protein-mRNA correlation |
| Treatment Control | Known inducers (e.g., DDC) or inhibitors | Verify biological responsiveness |
The use of MMP-1 knockout cell lines provides a gold standard for antibody specificity validation. Western blot analysis comparing parental PC-3 cells with MMP-1 knockout PC-3 cells shows a specific band at approximately 50 kDa only in the parental cell line, confirming antibody specificity .
How can MMP-1 antibodies be used to study cancer progression and metastasis?
MMP-1 antibodies enable multiple approaches for cancer research:
| Application | Methodology | Insight Gained |
|---|---|---|
| Expression Analysis in Tissues | IHC of tumor vs. normal tissue | Correlation with invasiveness |
| Metastatic Potential Assessment | WB/IHC comparing primary vs. metastatic sites | Changes during metastatic progression |
| Response to Treatment | WB of cells after therapeutic interventions | Drug efficacy on MMP-1 expression |
| Prognostic Biomarker Validation | IHC of patient samples with follow-up data | Correlation with clinical outcomes |
| Mechanistic Studies | Combined with pathway inhibitors | Signaling pathways regulating MMP-1 |
Studies have successfully used MMP-1 antibodies for the detection of MMP-1 in gastric cancer by both Western blotting and immunohistochemistry . The overexpression of MMP-1 in invasive melanoma, colorectal, and esophageal cancers highlights its potential value as a biomarker for cancer progression and metastasis .
What approaches can be used to study MMP-1 regulation in various cell types?
Multiple experimental approaches provide insights into MMP-1 regulation:
Research has demonstrated that co-culture of smooth muscle cells (SMCs) with macrophages in high glucose conditions significantly increases MMP-1 expression, which can be attenuated by silencing CCR2 or p65, indicating involvement of these pathways in MMP-1 regulation .
How do different experimental conditions affect MMP-1 expression and activity?
Environmental factors significantly impact MMP-1 expression:
Western blot analysis has shown that treatment with 100 μM DDC significantly upregulates MMP-1 expression, which can be attenuated by ERK1/2 inhibitor (U0126), p38 inhibitor (SB203580), or Akt inhibitor (T3830), indicating involvement of multiple signaling pathways in MMP-1 regulation .
How can I differentiate between pro-MMP-1 and active MMP-1 in my experiments?
Distinguishing between MMP-1 forms requires specific approaches:
Research has used antibodies like MAB901 for total MMP-1 detection and MAB3223 for specific detection of the active form, combined with casein zymography to assess enzymatic activity . This multi-method approach provides a more complete picture of MMP-1 expression and activation status.
What factors might affect MMP-1 antibody performance in my experiments?
Several experimental variables can influence antibody performance:
| Factor | Potential Impact | Mitigation Strategy |
|---|---|---|
| Sample Preparation | Altered epitope accessibility | Follow validated protocols |
| Buffer Composition | Changed antibody binding | Use recommended buffer systems |
| Antibody Concentration | Suboptimal signal or high background | Perform titration experiments |
| Incubation Parameters | Insufficient binding time/temperature | Follow recommended conditions |
| Detection System | Low sensitivity | Choose appropriate secondary reagents |
| Sample Type | Matrix effects | Validate across different sample types |
| Cross-reactivity | False positive signals | Verify with knockout controls |
| Antibody Storage | Reduced activity | Follow manufacturer storage guidelines |
Successful Western blot detection of MMP-1 has been achieved using PVDF membrane under reducing conditions with Immunoblot Buffer Group 1 and a primary antibody concentration of 2 μg/mL . Optimization of these parameters for each specific experimental setup is recommended.
How should I interpret contradictory results when studying MMP-1 expression?
When facing inconsistent results:
| Challenge | Investigative Approach | Validation Method |
|---|---|---|
| Discrepant Protein vs. mRNA Levels | Check post-transcriptional regulation | Compare RT-PCR with Western blot |
| Varying Results Across Methods | Use multiple detection techniques | Combine WB, IHC, ELISA, zymography |
| Antibody-Specific Differences | Test multiple antibodies | Compare different clones/epitopes |
| Cell Type-Dependent Variation | Account for biological context | Compare expression in different cell types |
| Temporal Expression Differences | Perform time-course experiments | Sample at multiple timepoints |
| Intracellular vs. Secreted MMP-1 | Analyze both cell lysates and media | Concentrate media for secreted proteins |
| Activation Status Confusion | Distinguish pro-form from active form | Use form-specific antibodies |
In DDC treatment studies, researchers correlated MMP-1 protein levels detected by Western blot with mRNA expression measured by quantitative RT-PCR and enzymatic activity assessed by casein zymography, providing a comprehensive view of MMP-1 regulation .
How is MMP-1 involved in various pathological conditions?
MMP-1 plays roles in multiple diseases:
Immunohistochemical analysis has demonstrated MMP-1 expression in human ovarian cancer tissue, and Western blot analysis has shown increased MMP-1 expression in smooth muscle cells co-cultured with macrophages under high glucose conditions, suggesting its role in both cancer and diabetes-related cardiovascular complications .
What is the relationship between MMP-1 and other MMPs in tissue remodeling?
MMPs function as a coordinated network:
Research has shown that protein expression of both MMP-1 and MMP-9 is significantly increased in smooth muscle cells after co-culture with macrophages in high glucose conditions, and inhibition of PKC alpha decreases the expression of both MMPs, suggesting shared regulatory mechanisms .
How does MMP-1 contribute to inflammation and repair processes?
MMP-1 functions in tissue homeostasis:
Western blot analysis has demonstrated that DDC treatment upregulates MMP-1 expression in an H₂O₂-associated manner and leads to decreased collagen I levels, highlighting MMP-1's role in the balance between matrix degradation and synthesis during tissue remodeling .
